Actionable news
0
All posts from Actionable news
Actionable news in CERS: Cerus Corporation,

Cantor Weighs In on Cerus Corporation (CERS) as FDA Halted Blood Donations in Two FL Counties Due to Zika

Cantor analyst Bryan Brokmeier reiterated a Buy rating on shares of Cerus Corporation (NASDAQ:CERS), with a $9.00 price target, after the FDA announced that it is requesting that all blood centers in Miami-Dade County and Broward County effectively stop collecting blood immediately, as health officials determine whether Zika has begun transmission in the continental United States. As a reminder, the FDA has approved a pathogen inactivation technology made by Cerus that kills the virus in blood platelets and plasma.

Brokmeier stated, “We recommend that...


More